source
- STAT seeks input on how Epic's practices affect hospital technology choicesEpic is the largest electronic health records vendor in the United States, with its systems used by most large health systems and covering the health data of roughly eight in ten Americans. Indust…
- Lilly’s ‘triple-G’ drug tops Novo’s Ozempic in diabetes trialThe highest dose of retatrutide beat Ozempic on measures of blood sugar and weight loss, but was also associated with higher side effect rates and treatment discontinuations.BioPharma Dive · 13d ago↗ source
- STAT+: Lilly’s triple-G drug beats Ozempic in head-to-head study